Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Watson Sells Stake In Taiwan’s ScinoPharm
by Jean-François Tremblay
March 8, 2010
| A version of this story appeared in
Volume 88, Issue 10
Watson Pharmaceuticals will sell its 31% stake in Taiwan’s ScinoPharm, a custom producer of active pharmaceutical ingredients, to Uni-President. A major food manufacturer in Taiwan and China, Uni-President already owns a substantial portion of ScinoPharm. The firm’s other major shareholders are Taiwan Sugar and the Taiwanese government. Watson started acquiring a stake in ScinoPharm in 2004 but says its priorities have changed now that it has increased its own manufacturing capability. In 2006, Watson acquired the Indian pharmaceutical ingredients maker Sekhsaria Chemicals.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter